Saturday, February 20, 2010
$25 million verdict vs manufacturer of Accutane acne drug
Last year, I reported that Roche Holding AG pulled its Accutane acne medicine from the U.S. market. Much of the debate over the drug related to whether it caused inflammatory bowel disease (see here and here). Interestingly, this week a New Jersey jury awarded $25.16 million in damages to a plaintiff who alleged that the acne drug caused the plaintiff to develop inflammatory bowel disease. Go here, here, here and here for more on this story . For more information on the debates related to Accutane go here.